D&D Pharmatech Raises $137.1M in Series B Financing to Advance Potential Disease-Modifying Treatments2019-08-142019-08-16http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.